Background
Methods
Patients
Statistical analysis
Results
Demographic data
NLR | ||||
---|---|---|---|---|
Variables | Cases | NLR ≤ 2.17 | NLR > 2.17 |
P
|
Age (years) | ||||
≤ 60 | 74 | 48 (64.9 %) | 26 (35.1 %) | |
> 60 | 67 | 46 (68.7 %) | 21 (31.3 %) | 0.633 |
Sex | ||||
Male | 137 | 90 (65.7 %) | 47 (34.3 %) | |
Female | 4 | 4 (100.0 %) | 0 | 0.151 |
Smoking history | ||||
Yes | 83 | 54 (65.1 %) | 29 (34.9 %) | |
No | 58 | 40 (69.0 %) | 18 (31.0 %) | 0.628 |
Drinking history | ||||
Yes | 24 | 15 (62.5 %) | 9 (37.5 %) | |
No | 117 | 79 (67.5 %) | 38 (32.5 %) | 0.635 |
T classification | ||||
T1–T2 | 86 | 62 (72.1 %) | 24 (27.9 %) | |
T3–T4 | 55 | 32 (58.2 %) | 23 (41.2 %) | 0.087 |
Lymph node metastasis | ||||
Negative | 118 | 80 (67.8 %) | 38 (32.2 %) | |
Positive | 23 | 14 (60.9 %) | 9 (39.1 %) | 0.519 |
Histological grade | ||||
Well | 48 | 34 (70.8 %) | 14 (29.2 %) | |
Moderately | 73 | 48 (65.8 %) | 25 (34.2 %) | |
Poorly | 20 | 12 (60.0 %) | 8 (40.0 %) | 0.670 |
Primary location | ||||
Supraglottic | 24 | 15 (62.5 %) | 9 (37.5 %) | |
Glottic | 113 | 77 (68.1 %) | 36 (31.9 %) | 0.671 |
Subglottic | 4 | 2 (50.0 %) | 2 (50.0 %) | |
Clinical stage | ||||
I–II | 80 | 58 (72.5 %) | 22 (27.5 %) | |
III–IV | 61 | 36 (59.0 %) | 25 (41.0 %) | 0.092 |
An optimal cutoff value for elevated NLR
DFS and OS according to NLR status
Risk factors for prognosis of LSCC
Variables |
n
| DFS | OS | ||||
---|---|---|---|---|---|---|---|
3-years | 5-years |
P
| 3-years | 5-years |
P
| ||
Age (years) | |||||||
≤ 60 | 74 | 65.6 % | 64.1 % | 75.7 % | 72.7 % | ||
> 60 | 67 | 69.4 % | 60.7 % | 0.980 | 80.6 % | 66.9 % | 0.41 |
Smoking history | |||||||
Yes | 83 | 68.3 % | 62.7 % | 74.7 % | 67.2 % | ||
No | 58 | 66.3 % | 62.2 % | 0.886 | 82.8 % | 73.0 % | 0.464 |
Drinking history | |||||||
Yes | 24 | 66.4 % | 61.7 % | 66.7 % | 61.1 % | ||
No | 117 | 67.7 % | 62.6 % | 0.845 | 80.3 % | 71.1 % | 0.414 |
T classification | |||||||
T1–T2 | 86 | 74.3 % | 68.6 % | 87.2 % | 79.6 % | ||
T3–T4 | 55 | 56.1 % | 51.8 % | 0.039 | 63.6 % | 53.7 % | 0.003 |
Lymph node metastasis | |||||||
Negative | 118 | 73.3 % | 68.4 % | 83.9 % | 75.9 % | ||
Positive | 23 | 35.5 % | 28.4 % | <0.001 | 47.8 % | 35.9 % | <0.001 |
NLR | |||||||
≤ 2.17 | 94 | 73.9 % | 69.1 % | 85.1 % | 77.4 % | ||
> 2.17 | 47 | 54.6 % | 49.2 % | 0.021 | 63.8 % | 53.3 % | 0.003 |
Histological grade | |||||||
Well | 48 | 83.0 % | 70.5 % | 93.7 % | 80.4 % | ||
Moderately | 73 | 59.6 % | 59.6 % | 74.0 % | 67.4 % | ||
Poorly | 20 | 59.6 % | 53.6 % | 0.169 | 55.0 % | 49.5 % | 0.043 |
Primary location | |||||||
Supraglottic | 24 | 55.9 % | 43.1 % | 58.3 % | 37.4 % | ||
Glottic | 113 | 69.5 % | 66.6 % | 82.3 % | 77.4 % | ||
Subglottic | 4 | 75.0 % | 50.0 % | 0.165 | 75.0 % | 50.0 % | 0.001 |
Clinical stage | |||||||
I–II | 80 | 74.9 % | 70.3 % | 87.5 % | 81.1 % | ||
III–IV | 61 | 57.2 % | 51.4 % | 0.022 | 65.6 % | 54.5 % | 0.004 |
Variables | DFS | OS | ||||
---|---|---|---|---|---|---|
HR | 95 % CI |
P
| HR | 95 % CI |
P
| |
T classification | 1.867 | 1.018–3.425 | 0.044 | |||
Lymph node metastasis | 3.224 | 1.751–5.937 | <0.001 | 2.968 | 1.548–5.692 | 0.001 |
NLR | 1.869 | 1.078–3.243 | 0.026 | 2.177 | 1.208–3.924 | 0.010 |